Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUPRENORPHINE Cause Completed suicide? 248 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 248 reports of Completed suicide have been filed in association with BUPRENORPHINE (Buprenorphine and Naloxone). This represents 0.3% of all adverse event reports for BUPRENORPHINE.

248
Reports of Completed suicide with BUPRENORPHINE
0.3%
of all BUPRENORPHINE reports
242
Deaths
43
Hospitalizations

How Dangerous Is Completed suicide From BUPRENORPHINE?

Of the 248 reports, 242 (97.6%) resulted in death, 43 (17.3%) required hospitalization, and 5 (2.0%) were considered life-threatening.

Is Completed suicide Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUPRENORPHINE. However, 248 reports have been filed with the FAERS database.

What Other Side Effects Does BUPRENORPHINE Cause?

Drug dependence (16,730) Overdose (13,977) Death (13,604) Toxicity to various agents (10,906) Pain (8,219) Drug withdrawal syndrome (7,149) Emotional distress (6,159) Drug abuse (4,344) Drug ineffective (4,261) Dependence (3,184)

What Other Drugs Cause Completed suicide?

ACETAMINOPHEN (6,052) ALCOHOL (5,569) AMLODIPINE (5,267) BUPROPION (5,095) QUETIAPINE (4,997) ALPRAZOLAM (4,873) OXYCODONE (4,330) GABAPENTIN (4,111) ACETAMINOPHEN\HYDROCODONE (3,366) CLONAZEPAM (3,320)

Which BUPRENORPHINE Alternatives Have Lower Completed suicide Risk?

BUPRENORPHINE vs BUPRENORPHINE\NALOXONE BUPRENORPHINE vs BUPROPION BUPRENORPHINE vs BUPROPION HYDROBROMIDE BUPRENORPHINE vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE BUPRENORPHINE vs BUPROPION\NALTREXONE

Related Pages

BUPRENORPHINE Full Profile All Completed suicide Reports All Drugs Causing Completed suicide BUPRENORPHINE Demographics